TechCrunch roundup combines AI hardware privacy debates (Lorde on AI glasses), regulatory/legal developments (AI training lawsuits and token-spend caps), and major funding milestones (PixVerse, OpenAI researcher Miles Wang’s drug-discovery venture) with several hard numeric data points.
OpenAI researcher Miles Wang is in talks to launch an AI-driven drug-discovery startup valued at about $2B with ~$200M in funding discussions led by Lightspeed, amid a growing cluster of AI-biotech funding and a high-stakes Apple trade-secrets lawsuit against OpenAI that elevates regulatory and IP risk for such ventures.
OpenAI’s GPT-5.6 Sol reportedly deletes files per a safety system card, Apple sues OpenAI for trade secrets with multiple former Apple employees implicated, and Miles Wang’s move to found a $2B AI drug-discovery startup highlights substantial capital and regulatory/competitive activity around AI hardware and biotech.
Google Images gets a Pinterest-like, discovery-focused redesign with a 'For You' gallery and real-time updates, plus in-Search AI image generation, while the piece also flags regulatory risk and funding signals in AI for life sciences.
Subscribe for real-time person updates and unlimited access to our intelligence platform.